These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 23089672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I, Ingelman-Sundberg M.
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF, Liu JP, Chowbay B.
    Drug Metab Rev; 2009 Mar; 41(2):89-295. PubMed ID: 19514967
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.
    Stingl JC, Brockmöller J, Viviani R.
    Mol Psychiatry; 2013 Mar; 18(3):273-87. PubMed ID: 22565785
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A, Backman JT.
    Adv Pharmacol; 2018 Mar; 83():3-32. PubMed ID: 29801580
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation.
    Ragia G, Pallikarou M, Manolopoulou Y, Vorvolakos T, Manolopoulos VG.
    Pharmacogenomics; 2024 Mar; 25(5-6):217-229. PubMed ID: 38884939
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme].
    Zhao L, Lou YQ.
    Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):35-40. PubMed ID: 10921075
    [Abstract] [Full Text] [Related]

  • 15. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A, Kirchheiner J.
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.